Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00602433 · ClinicalTrials.gov registry record
Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 10
- Enrollment target
NCT00602433 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 10 participants.
The verdict
NCT00602433 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
Studying samples of blood in the laboratory from patients receiving erlotinib may help doctors learn more about the effects of erlotinib on hormone levels. This clinical trial is looking at hormone changes in women with stage IIIB or stage IV non-small cell lung cancer receiving erlotinib.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-12 |
| Est. Completion | 2009-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00602433
The ClinicalTrials.gov registry entry for NCT00602433 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00602433 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00602433 about?
NCT00602433 is a clinical study titled "Hormone Changes in Women With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Receiving Erlotinib". Studying samples of blood in the laboratory from patients receiving erlotinib may help doctors learn more about the effects of erlotinib on hormone levels. This clinical trial is looking at hormone changes in women with stage IIIB or stage IV non-small cell lung cancer receiving erlotinib.
What is the current status of trial NCT00602433?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2007-12. Estimated completion is 2009-08.
Who is sponsoring clinical trial NCT00602433?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.